Codexis, Inc. (CDXS): Price and Financial Metrics
Codexis, Inc. (CDXS)
Today's Latest Price: $12.42 USD
0.19 (-1.51%)
Updated May 29 6:55pm
Add CDXS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
CDXS Stock Summary
- CDXS's price/sales ratio is 10.85; that's higher than the P/S ratio of 89.37% of US stocks.
- CDXS's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of just 21.73% of US stocks.
- Over the past twelve months, CDXS has reported earnings growth of 27.12%, putting it ahead of 75.78% of US stocks in our set.
- Stocks that are quantitatively similar to CDXS, based on their financial statements, market capitalization, and price volatility, are CERS, HTBX, CAPR, PTCT, and PSNL.
- Visit CDXS's SEC page to see the company's official filings. To visit the company's web site, go to www.codexis.com.
CDXS Daily Price Range
CDXS 52-Week Price Range
CDXS Stock Price Chart More Charts
CDXS Price/Volume Stats
| Current price | $12.42 | 52-week high | $19.32 |
| Prev. close | $12.61 | 52-week low | $8.43 |
| Day low | $12.12 | Volume | 386,900 |
| Day high | $12.65 | Avg. volume | 416,188 |
| 50-day MA | $11.06 | Dividend yield | N/A |
| 200-day MA | $13.65 | Market Cap | 733.00M |
Codexis, Inc. (CDXS) Company Bio
Codexis, Inc. develops biocatalysts for the pharmaceutical and fine chemicals markets in the United States and internationally. The company offers Codex biocatalyst panels and kits to pharmaceutical companies that are engaged in drug development and the marketing of approved drugs to allow them to screen and identify possible enzymatic manufacturing processes for their drug candidates and their marketed products. The company was founded in 2002 and is based in Redwood City, California.
Loading social stream, please wait...